Relationship between HbA1c and Time in range in the treatment of diabetes

Relationship between HbA1c and Time in range in the treatment of diabetes - Relationship between HbA1c and Time in range in the treatment of diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047337

Enrollment

120

Registered

2022-03-31

Start date

2021-01-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diabetic patients using continuous blood glucose monitoring

Exclusion criteria

Exclusion criteria: 1 Patients with mechanical failure of continuous glucose monitoring during the study period 2 Diabetic patients not using continuous glucose monitoring 3 Patient with intolerance of medical reasons by doctor

Design outcomes

Primary

Measure	Time frame
time in range (%)	—

Secondary

Measure	Time frame
Red blood cell count, white blood cell count, Hemoglobin, hematocrit, platelet count, total protein, albumin, AST, ALT, BUN, creatinine, eGFR, glucose, glycoalbumin, Urine albumin / creatinine ratio, data from a continuous glucose monitoring	—

Countries

Japan

Contacts

Public ContactToshie Iijima

Dokkyo Medical University Department of Endocrinology and Metabolism

toshie@dokkyomed.ac.jp0282861111

Outcome results